Harry K. Slocum

Basis for natural variation in sensitivity to 5-fluorouracil in mouse and human cells in culture.

Jeffrey D. Laskin, Ronald M. Evans, Harry K. Slocum et al. · PubMed · 1979 · 104 citations

Medicine, Biochemistry, Pharmacology +15

Super in vitro synergy between inhibitors of dihydrofolate reductase and inhibitors of other folate-requiring enzymes: the critical role of polyglutamylation.

Hélène M. Faessel, Harry K. Slocum, Robert Jackson et al. · PubMed · 1998 · 33 citations

Life Sciences, Biochemistry, Pharmacology +16

Combined action of paclitaxel and cisplatin against wildtype and resistant human ovarian carcinoma cells

Laurence M. Levasseur, William R. Greco, Y M Rustum et al. · Cancer Chemotherapy and Pharmacology · 1997 · 29 citations

Medicine, Oncology, Pharmacology +12

Growth of human urological tumors on extracellular matrix as a model for the in vitro cultivation of primary human tumor explants.

Krešimir Pavelić, Muhammad Bulbul, Harry K. Slocum et al. · PubMed · 1986 · 22 citations

Life Sciences, Cell Biology, Oncology +16

Folic acid-enhanced synergy for the combination of trimetrexate plus the glycinamide ribonucleotide formyltransferase inhibitor 4-[2-(2-Amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimidino[5,4,6][1,4]thiazin-6-yl)-(S)-ethyl]-2,5-thienoylamino-l-glutamic acid (AG2034)

Hélène M. Faessel, Harry K. Slocum, Y M Rustum et al. · Biochemical Pharmacology · 1999 · 14 citations

Life Sciences, Pharmacology, Pharmacotherapy +13